AU781846B2 - Antithrombotic compound - Google Patents

Antithrombotic compound Download PDF

Info

Publication number
AU781846B2
AU781846B2 AU20038/01A AU2003801A AU781846B2 AU 781846 B2 AU781846 B2 AU 781846B2 AU 20038/01 A AU20038/01 A AU 20038/01A AU 2003801 A AU2003801 A AU 2003801A AU 781846 B2 AU781846 B2 AU 781846B2
Authority
AU
Australia
Prior art keywords
compound
och
formula
spacer
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU20038/01A
Other languages
English (en)
Other versions
AU2003801A (en
Inventor
Tamara Theodora Maria Geertsen
Cornelia Maria Tromp
Constant Adriaan Anton Van Boeckel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme BV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2003801A publication Critical patent/AU2003801A/en
Application granted granted Critical
Publication of AU781846B2 publication Critical patent/AU781846B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU20038/01A 1999-12-07 2000-12-01 Antithrombotic compound Expired AU781846B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07
EP99204172 1999-12-07
PCT/EP2000/012155 WO2001042262A2 (en) 1999-12-07 2000-12-01 Antithrombotic compound

Publications (2)

Publication Number Publication Date
AU2003801A AU2003801A (en) 2001-06-18
AU781846B2 true AU781846B2 (en) 2005-06-16

Family

ID=8240976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20038/01A Expired AU781846B2 (en) 1999-12-07 2000-12-01 Antithrombotic compound

Country Status (23)

Country Link
US (1) US6875755B2 (enExample)
EP (1) EP1237897B1 (enExample)
JP (1) JP4820517B2 (enExample)
KR (1) KR100776607B1 (enExample)
CN (1) CN1195767C (enExample)
AR (1) AR026726A1 (enExample)
AU (1) AU781846B2 (enExample)
BR (1) BR0016217A (enExample)
CA (1) CA2393042C (enExample)
CO (1) CO5251449A1 (enExample)
CZ (1) CZ303385B6 (enExample)
HK (1) HK1047593A1 (enExample)
HU (1) HUP0203471A3 (enExample)
IL (2) IL149628A0 (enExample)
NO (1) NO323059B1 (enExample)
NZ (1) NZ519100A (enExample)
PE (1) PE20010935A1 (enExample)
PL (1) PL202840B1 (enExample)
RU (1) RU2266913C2 (enExample)
SK (1) SK287682B6 (enExample)
TW (1) TWI289566B (enExample)
WO (1) WO2001042262A2 (enExample)
ZA (1) ZA200203799B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2557086A3 (en) * 2001-09-07 2014-11-05 Alchemia Limited Synthetic heparin pentasaccharides
WO2004007468A1 (en) 2002-07-15 2004-01-22 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
WO2004032836A2 (en) 2002-10-07 2004-04-22 Merck & Co., Inc. Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors
JP4413863B2 (ja) 2002-11-07 2010-02-10 メルク エンド カムパニー インコーポレーテッド 糖尿病の治療又は予防のためのジペチジルペプチダーゼ阻害剤としてのフェニルアラニン誘導体
CA2512546A1 (en) 2003-01-17 2004-08-05 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
JP2006516573A (ja) 2003-01-31 2006-07-06 メルク　エンド　カムパニー　インコーポレーテッド 糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての３−アミノ−４−フェニルブタン酸誘導体
WO2004103276A2 (en) 2003-05-14 2004-12-02 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004110436A1 (en) 2003-06-06 2004-12-23 Merck & Co., Inc. Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US7456204B2 (en) 2003-06-17 2008-11-25 Merck & Co., Inc. Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CN1882551A (zh) 2003-07-31 2006-12-20 麦克公司 用作用于治疗或预防糖尿病的二肽基肽酶－iv酶抑制剂的六氢二氮杂吖庚因酮
EP1574516A1 (en) 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
HRP20110331T1 (hr) * 2005-10-10 2011-06-30 N.V. Organon Antikoagulantno-antitrombotski dvojni inhibitori, koji sadrže biotinski biljeg
CN102892411B (zh) 2009-12-18 2015-01-21 恩多提斯药业公司 含有合成的低聚糖的药物口服剂型

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4512999A (en) * 1998-06-17 2000-01-05 Merck Sharp & Dohme B.V. Antithrombotic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2147216T3 (es) * 1993-09-01 2000-09-01 Akzo Nobel Nv Bisconjugados que comprenden dos sacaridos y un grupo de union.
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4512999A (en) * 1998-06-17 2000-01-05 Merck Sharp & Dohme B.V. Antithrombotic compounds

Also Published As

Publication number Publication date
KR20020070988A (ko) 2002-09-11
NO20022689D0 (no) 2002-06-06
RU2266913C2 (ru) 2005-12-27
US20030114361A1 (en) 2003-06-19
PL202840B1 (pl) 2009-07-31
JP4820517B2 (ja) 2011-11-24
EP1237897B1 (en) 2015-01-14
NO20022689L (no) 2002-06-06
KR100776607B1 (ko) 2007-11-16
CA2393042C (en) 2011-06-28
CZ303385B6 (cs) 2012-08-29
BR0016217A (pt) 2002-09-10
PL355484A1 (en) 2004-05-04
CZ20021958A3 (cs) 2002-08-14
WO2001042262A3 (en) 2001-12-13
ZA200203799B (en) 2003-10-29
AU2003801A (en) 2001-06-18
CA2393042A1 (en) 2001-06-14
AR026726A1 (es) 2003-02-26
CN1195767C (zh) 2005-04-06
EP1237897A2 (en) 2002-09-11
SK287682B6 (sk) 2011-06-06
SK7942002A3 (en) 2002-09-10
NZ519100A (en) 2004-09-24
PE20010935A1 (es) 2001-09-20
WO2001042262A2 (en) 2001-06-14
HUP0203471A3 (en) 2003-03-28
CO5251449A1 (es) 2003-02-28
IL149628A0 (en) 2002-11-10
TWI289566B (en) 2007-11-11
HK1047593A1 (zh) 2003-02-28
US6875755B2 (en) 2005-04-05
NO323059B1 (no) 2006-12-27
CN1407989A (zh) 2003-04-02
JP2003520208A (ja) 2003-07-02
HUP0203471A2 (hu) 2003-02-28
IL149628A (en) 2010-04-29

Similar Documents

Publication Publication Date Title
EP1237897B1 (en) Antithrombotic compound
CA2334863C (en) Antithrombotic compounds
US5556941A (en) Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
US7576071B2 (en) Antithrombotic compound
MXPA02005278A (en) Antithrombotic compound
HK1034266B (en) Antithrombotic compounds
MXPA06010046A (en) Antithrombotic compound
MXPA00012554A (en) Antithrombotic compounds

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: AKZO NOBEL N.V., SANOFI-SYNTHELABO

Free format text: THE FORMER OWNER WAS: AKZO NOBEL N.V.

PC1 Assignment before grant (sect. 113)

Owner name: SANOFI-SYNTHELABO

Free format text: THE FORMER OWNER WAS: AKZO NOBEL N.V., SANOFI-SYNTHELABO

TH Corrigenda

Free format text: IN VOL 18, NO 14, PAGE(S) 399 UNDER THE HEADING ASSIGNMENTS BEFORE GRANT, SECTION 113 DELETE ALL REFERENCE TO PATENT APPLICATION NO. 20038/01

MK14 Patent ceased section 143(a) (annual fees not paid) or expired